Guilherme H M Salvador, Êmylle K R Pinto, Paula L Ortolani, Consuelo L Fortes-Dias, Walter L G Cavalcante, Andreimar M Soares, Bruno Lomonte, Matthew R Lewin, Marcos R M Fontes
Varespladib (LY315920) is a potent inhibitor of human group IIA phospholipase A2 (PLA2 ) originally developed to control inflammatory cascades of diseases associated with high or dysregulated levels of endogenous PLA2 . Recently, varespladib was also found to inhibit snake venom PLA2 and PLA2 -like toxins. Herein, ex vivo neuromuscular blocking activity assays were used to test the inhibitory activity of varespladib. The binding affinity between varespladib and a PLA2 -like toxin was quantified and compared with other potential inhibitors for this class of proteins...
November 17, 2022: Biochimie